Companies: 10,795·Total market cap: $144.5T
Baxter International Inc.

Baxter International Inc.

BAXNYSEHealthcare● Active
$19.27
$-0.12(-0.59%)
Market Cap$9.9B
P/E Ratio
52W High$32.04
52W Low$15.73
Overview

Baxter International Inc. (BAX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BAX · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.97B +11.5% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$1.97B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+11.5%
vs prior fiscal year
Latest Quarter
$2.02B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$1.97BCash on Hand
Total Debt$10.00BTotal Debt
Net Cash / Net Debt−$8.04BNet Debt Position
Cash vs Debt Ratio
Cash 16%Debt 84%

Baxter International Inc. carries a net debt position of $8.04B. Total debt ($10.00B) exceeds cash on hand ($1.97B). Baxter International Inc. cash vs debt ratio: 16% cash / 84% debt.

Net Cash = Cash & ST Investments − Total Debt$1.97B$10.00B = −$8.04B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
BAX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$1.97B+11.5%
Dec 31, 2024$1.76B-42.7%
Dec 31, 2023$3.08B+79.2%
Dec 31, 2022$1.72B-41.8%
Dec 31, 2021$2.95B-20.9%
BAX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Baxter International Inc.
Baxter International Inc.YOU
BAX
$1.97B19.6%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Baxter International Inc. (BAX) cash on hand as of December 31, 2025 is $1.97B, comprising $1.97B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Baxter International Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Baxter International Inc. cash reserves or cash position.

Baxter International Inc. annual cash on hand history shows increased +11.5% in 2025: increased +11.5% in 2025. Baxter International Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Baxter International Inc. carries total debt of $10.00B against cash of $1.97B, resulting in a net debt position of -$8.04B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

BAX cash on hand · 5 questions

As of December 31, 2025, Baxter International Inc. (BAX) has $1.97B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.97B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $2.02B. Data sourced from the annual 10-K filing via FMP.

BAX cash on handBAX cash reservesBAX cash 2025how much cash does BAX have

Source: FMP /balance-sheet-statement · US GAAP · Baxter International Inc. · Baxter International Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025